Cannell Thomas R 4
4 · Sesen Bio, Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Sesen Bio, Inc.SESN
Cannell Thomas R
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-02-18+606,800→ 606,800 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc.(the "Company"). Each RSU represents a contingent right to receive one share of the Company's common stock. Based on market analysis by Radford of public, pre-commercial and commercial biopharmaceutical companies, the compensation committee of the Company recommended to the Company's board of directors, and the board of directors approved, the grant to the reporting person.